Virtual patients could reshape how drug trials are run, says a short techbio lecture
dom_beaini · x · 2026-07-24
> The post contrasts two drug-discovery problems: designing better molecules for a target versus designing drugs that actually succeed in clinical trials.
It points readers to a short lecture on virtual patients, described as AI models that could fundamentally change how drug trials are run. The referenced Valence Labs series, “Valence at the Whiteboard,” introduces modern drug-discovery concepts one by one.
More from Apps
- OpenAI brings ChatGPT Voice to desktop, letting users steer multiple agents by voice — Dimillian · 2026-07-24
- WAIC demo shows an AI teaching board that turns lessons into interactive classrooms — Roger_M_Taylor · 2026-07-24
- ChatGPT Desktop adds conversation scrolling to Codex Micro’s knob — Dimillian · 2026-07-24
- ChatGPT Work demo turns meeting notes into slides and a Slack update — dkundel · 2026-07-24
- Stream Chat demos Apple Intelligence writing tools in an iOS SwiftUI app — amos_gyamfi · 2026-07-24
- OpenAI makes Sites Analytics public for Codex-published websites — OpenAIDevs · 2026-07-24